HRT Financial’s Revelation Biosciences Warrant REVBW Stock Holding History

HRT Financial’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,144	Closed	–	–	3388
2025 Q1	$0	Buy	+13,144	New	+$202	﹤0.01%	3250
2022 Q2	–	Sell	-37,160	Closed	-$4K	–	3594
2022 Q1	$4K	Hold	37,160	–	–	﹤0.01%	2966
2021 Q4	$25K	Buy	+37,160	New	+$22.8K	﹤0.01%	2921

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's REVBW Position: Q2 2025 in Review

HRT Financial sold out of Revelation Biosciences Warrant (REVBW) in Q2 2025, closing a stake of 13,144 shares.

HRT Financial first reported a position in REVBW in Q4 2021 and held it in 3 quarters. The position peaked at $25K in Q4 2021. 12 funds tracked by Wall St. Rank hold REVBW as of Q2 2025.

HRT Financial reported no remaining Revelation Biosciences Warrant position as of Q2 2025 after selling out during the quarter.
HRT Financial sold 13,144 Revelation Biosciences Warrant shares in Q2 2025.
HRT Financial first reported a position in Revelation Biosciences Warrant in Q4 2021 and held it in 3 quarters.
HRT Financial's Revelation Biosciences Warrant position peaked at $25K in Q4 2021.
12 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.